Sudan's Medical and Humanitarian Crisis

Sudan’s medical and humanitarian crisis, as recounted in the book, was the extended consequence of the destruction of the Al-Shifa pharmaceutical factory in August 1998. Al-Shifa had supplied affordable medicines across a country with widespread disease and fragile infrastructure. Its loss, compounded by sanctions and disruptions to humanitarian work, made the bombing consequential well beyond the immediate damage to the facility: the book traces its effects through medicine shortages, preventable illness, relief delays, and a setback to efforts to end Sudan’s civil war.

The factory and the medical supply gap

The evidence describes Al-Shifa as central to Sudan’s supply of basic medicine. One contemporary account cited in the book said the factory produced 90 percent of the medicines most commonly used in the country. Another put its share at 50 percent and emphasized that its destruction left Sudan without a reserve of chloroquine, the usual treatment for malaria. The varying estimates in the cited reports underline the factory’s importance without making its exact share uniform across sources.

Al-Shifa’s role extended beyond malaria treatment. It was reportedly the only domestic facility producing medicines for tuberculosis, serving more than 100,000 patients at a cost of about one British pound per month. Imported substitutes were more expensive and beyond the reach of many patients and their families. In a country described as predominantly pastoral, the factory was also the sole producer of veterinary medicines. Its treatments addressed parasites that pass from livestock to herders, a source of infant mortality.

The loss became harder to remedy because Sudan was under sanctions that prevented it from importing enough pharmaceuticals to replace the factory’s output. Months after the bombing, the British Labour government refused Sudan’s request for an emergency supply of chloroquine until the country could restore its own production. The crisis was therefore not simply a matter of one damaged plant: the destruction removed domestic capacity, while restrictions and the unaffordability of imported alternatives constrained replacement.

Disease, poverty, and delayed mortality

The book situates the medicine shortage within Sudan’s broader vulnerability. Technical reports by the Near East Foundation describe restricted arable land, chronic shortages of safe drinking water, high mortality, little industry, heavy debt, the burden of AIDS, a devastating civil war, and severe sanctions. The country also faced endemic malaria and tuberculosis, alongside periodic meningitis and cholera outbreaks. In those conditions, affordable medicines were a basic requirement for survival rather than a dispensable commodity.

A year after the attack, a report cited from the Boston Globe said that the absence of medicines produced by the destroyed facility was associated with a continuing rise in deaths. It reported that tens of thousands of people, most of them children, were suffering and dying from malaria, tuberculosis, and other treatable diseases. Jonathan Belke, drawing on field experience in Sudan, considered it plausible that tens of thousands had already become ill and died within a year as a direct consequence of losing the country’s largest producer of affordable medicines and veterinary products. The book presents this figure as an estimate, not a definitive count: the delayed deaths were difficult to establish, and the scale of the harm could only be inferred from the available reporting.

The author’s account insists that an assessment must include people who suffered the consequences of the loss, not only those killed at Khartoum by cruise missiles. That distinction shifts attention from an immediate toll to the longer chain linking a destroyed source of medicine with untreated disease and death. It also explains why the crisis could remain largely unseen: its consequences accumulated over time rather than appearing as a single, easily counted event.

Humanitarian relief and the blocked peace process

The bombing also affected humanitarian work beyond the supply of medicines. According to a contemporaneous Human Rights Watch report cited in the book, United Nations agencies headquartered in Khartoum evacuated their American staff after the attack, and many other relief organizations followed. Aid efforts were delayed for an undetermined period. Among them was a major American-led International Rescue Committee project in a government-held town, where more than 50 people from the south were reported to be dying each day.

The need was acute: the United Nations estimated that 2.4 million people in some parts of southern Sudan faced the risk of starvation. Human Rights Watch warned that interrupting assistance to populations already devastated by conflict could produce a severe crisis. In this account, the consequences of the bombing included not only the loss of medicine-making capacity but also a disruption to organizations trying to meet urgent needs elsewhere in the country.

The attack was also reported to have interrupted a slow movement toward compromise among Sudan’s warring parties. Mark Huband’s account in the Financial Times said the bombing appeared to halt momentum toward a peace treaty that might have ended a civil war in which 1.5 million people had died since 1981. The process might also have contributed to peace in Uganda and across the Nile basin. Huband linked the reversal to a political shift within Sudan’s Islamist government: the government had been moving toward pragmatic engagement with the outside world, attempting to address internal crises, stop supporting terrorism, and reduce the influence of radical Islamists. The bombing, in this reading, damaged both the country’s fragile medical services and the opening for political change.

Scale, comparison, and political aftermath

The book uses comparisons to communicate the crisis’s scale while noting their limits. It asks readers to imagine an attack that destroyed half of the United States’ pharmaceutical reserves and the facilities needed to replenish them, but stresses that the analogy is unequal because the consequences for Sudan were far more severe. Sudan’s poverty, dispersed population, difficult climate, weak infrastructure, health risks, and limited capacity to import medicine made the same kind of destruction more consequential there.

Three years after the bombing, James Astill revisited its political cost in the Guardian, describing the country as one trying to emerge from military dictatorship, destructive Islamism, and a prolonged civil war. He argued that the attack had returned Khartoum to a condition of politically weakened extremism overnight, and suggested that the damage to Sudan’s fragile medical services might have been outweighed by the political cost. The account therefore treats the medical emergency and political reversal as connected consequences, not competing explanations of the attack’s significance.

Dr. Idris Eltayeb, one of Sudan’s few pharmacologists and chair of Al-Shifa’s board, called the bombing an act of terrorism and compared it with the attacks on the Twin Towers. He expressed sorrow for those killed in New York and Washington, while arguing that, measured in numbers and relative cost to a poor country, the bombing’s consequences for Sudan were worse. The book does not present that comparison as a settled statistical calculation. It concludes more cautiously that Eltayeb might have been right about the number of lives lost, even without counting the long-term political cost. In that unresolved accounting, the crisis’s defining feature is its duration: a destroyed factory, restrictions on replacement supplies, and interrupted relief produced consequences that continued after the immediate event had passed.